Abstract
The efficacy of high-dose intramuscular MPA therapy in controlling progressive measurable metastatic breast carcinoma was assessed in 32 women. In addition serial measurements of MPA blood levels were carried out in 20 of the patients and subjective effects of treatment were monitored in detail in 18 of the women. Overall 6 patients (19%) gained an objective response and a further 7 (22%) experienced disease stasis from 4-17 months whilst on treatment. Significant differences in serum MPA levels were seen between responders and non-responders, objective tumour shrinkage only being seen in those patients who rapidly attained, and sustained, blood levels in excess of 100 ng ml-1. Subjective assessment showed no evidence of a euphoriant effect of MPA therapy in the non-responders group.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Cuna G. R., Calciati A., Strada M. R., Bumma C., Campio L. High dose medroxyprogesterone acetate (MPA) treatment in metastatic carcinoma of the breast: a dose-response evaluation. Tumori. 1978 Apr 30;64(2):143–149. doi: 10.1177/030089167806400204. [DOI] [PubMed] [Google Scholar]
- Ganzina F. High-dose medroxyprogesterone acetate (MPA) treatment in advanced breast cancer. A review. Tumori. 1979 Oct 31;65(5):563–585. doi: 10.1177/030089167906500507. [DOI] [PubMed] [Google Scholar]
- Mathrubutham M., Fotherby K. Medroxyprogesterone acetate in human serum. J Steroid Biochem. 1981 Aug;14(8):783–786. doi: 10.1016/0022-4731(81)90015-7. [DOI] [PubMed] [Google Scholar]
- Pannuti F., Martoni A., Di Marco A. R., Piana E., Saccani F., Becchi G., Mattioli G., Barbanti F., Marra G. A., Persiani W. Prospective, randomized clinical trial of two different high dosages of medroxyprogesterone acetate (MAP) in the treatment of metastatic breast cancer. Eur J Cancer. 1979 Apr;15(4):593–601. doi: 10.1016/0014-2964(79)90097-5. [DOI] [PubMed] [Google Scholar]
- Salimtschik M., Mouridsen H. T., Loeber J., Johansson E. Comparative pharmacokinetics of medroxyprogesterone acetate administered by oral and intramuscular routes. Cancer Chemother Pharmacol. 1980;4(4):267–269. doi: 10.1007/BF00255272. [DOI] [PubMed] [Google Scholar]
- Shrimanker K., Saxena B. N., Fotherby K. A radioimmunoassay for serum medroxyprogesterone acetate. J Steroid Biochem. 1978 Apr;9(4):359–363. doi: 10.1016/0022-4731(78)90631-3. [DOI] [PubMed] [Google Scholar]